Co‐expression of <scp>LAG</scp>3 and <scp>TIM</scp>3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients

Qiang Ma, Junning Liu, Guoliang Wu, Mujian Teng, Shaoxuan Wang, Meng Cui, Yuantao Li

Clinical and Experimental Pharmacology and Physiology · 2018 · 42 citations · 15 references

Concepts

Abstract

Summary Regulatory T (Treg) cells are critical suppressors of inflammation and are thought to exert mainly deleterious effects in cancers. In colorectal cancer ( CRC ), Foxp3 + Treg accumulation in tumors was associated with poor prognosis. Hence, we examined the circulating Treg cells in CRC patients. Compared to controls, CRC patients presented mild upregulations in CD 4 + CD 25 +/hi T cells and in the more canonical CD 4 + CD 25 +/hi Foxp3 + Treg cells in peripheral blood mononuclear cells. Both of these Treg populations could be roughly divided into lymphocyte activation gene 3 negative T cell immunoglobulin and mucin‐domain containing‐3 negative ( LAG 3 − TIM 3 − ) and LAG 3 + TIM 3 + subsets. In CRC patients, the LAG 3 + TIM 3 + subset represented approximately half of CD 4 + CD 25 +/hi T cells and greater than 60% of CD 4 + CD 25 +/hi Foxp3 + Treg cells, which was significantly more frequent than in healthy controls. Compared to the LAG 3 − TIM 3 − CD 4 + CD 25 +/hi T cells, the LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells presented considerably higher transforming growth factor‐β and slightly higher interleukin ( IL )‐10 secretion, together with higher cytotoxic T‐lymphocyte associated protein 4 and Foxp3 expression levels. Notably, macrophages following incubation with LAG 3 − TIM 3 − CD 4 + CD 25 +/hi T cells and LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells displayed different characteristics. Macrophages incubated with LAG 3 + TIM 3 + CD 4 + CD 25 +/hi T cells presented lower expression of major histocompatibility complex class II , CD 80, CD 86, and tumor necrosis factor‐α but higher expression of IL ‐10, than macrophages incubated with LAG 3 − TIM 3 − CD 4 + CD 25 +/hi T cells. Together, our investigations demonstrated that CRC patients presented an enrichment of circulating Treg cells, in which the LAG 3 + TIM 3 + subset exhibited more potent expression of inhibitory molecules, and furthermore, the LAG 3 + TIM 3 + Treg cells could suppress the proinflammatory activation of macrophages more potently than the LAG 3 − TIM 3 − Treg cells.

References

15